Science Explorer Back to mapMap
Discussion
Company · Gembloux · Belgium

Coris BioConcept (Belgium)

corisbio.com/#ROR OpenAlex
Research works
14
▼ 79% vs 2018-21
Citations
384
27.9 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
55%
world 40%
International
82%
world 18%
Coris BioConcept (Belgium)

Not ranked overall: Coris BioConcept (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Coris BioConcept (Belgium) work in?

In all years, 51% of research at Coris BioConcept (Belgium) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (48%), Immunology and Microbiology (17%), Biochemistry, Genetics and Molecular Biology (11%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 7 fractional works · 50.6% of its workMedicine: 7 fractional works · 47.6% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 17.8% of its workEpidemiology: 2 fractional works · 16.2% of its workInfectious Diseases: 0 fractional works · 3.4% of its workPharmacology: 0 fractional works · 2.6% of its workSurgery: 0 fractional works · 2.1% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 2.0% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.9% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 1.0% of its workRehabilitation: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 1.2% of its workNutrition and Dietetics: 0 fractional works · 1.2% of its workHealth Professions: 0 fractional works · 0.9% of its workGeneral Health Professions: 0 fractional works · 0.5% of its workRadiological and Ultrasound Technology: 0 fractional works · 0.5% of its workVeterinary: 0 fractional works · 0.8% of its workSmall Animals: 0 fractional works · 0.8% of its workLife Sciences: 5 fractional works · 32.8% of its workImmunology and Microbiology: 2 fractional works · 16.5% of its workParasitology: 2 fractional works · 11.5% of its workImmunology: 0 fractional works · 3.6% of its workVirology: 0 fractional works · 0.8% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.6% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 11.4% of its workMolecular Biology: 1 fractional works · 4.8% of its workMolecular Medicine: 0 fractional works · 3.6% of its workClinical Biochemistry: 0 fractional works · 1.7% of its workEndocrinology: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 4.9% of its workInsect Science: 0 fractional works · 2.4% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 1.4% of its workAnimal Science and Zoology: 0 fractional works · 0.8% of its workFood Science: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 2 fractional works · 15.7% of its workEngineering: 1 fractional works · 9.5% of its workBiomedical Engineering: 1 fractional works · 5.9% of its workElectrical and Electronic Engineering: 0 fractional works · 3.0% of its workMechanics of Materials: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 2.0% of its workEcology: 0 fractional works · 1.6% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.4% of its workPhysics and Astronomy: 0 fractional works · 2.0% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 1.6% of its workAstronomy and Astrophysics: 0 fractional works · 0.4% of its workChemical Engineering: 0 fractional works · 1.2% of its workBioengineering: 0 fractional works · 1.2% of its workChemistry: 0 fractional works · 0.9% of its workSpectroscopy: 0 fractional works · 0.9% of its workSocial Sciences: 0 fractional works · 0.9% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.9% of its workEconomics and Econometrics: 0 fractional works · 0.9% of its workALL ITS WORKCoris BioConcept(Belgium)14fractional works, all years
Life Sciences33%Physical Sciences16%Health Sciences51%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine747.6%
    2. Nursing01.2%
    3. Health Professions00.9%
    4. Veterinary00.8%
    1. Immunology and Microbiology216.5%
    2. Biochemistry, Genetics and Molecular Biology211.4%
    3. Agricultural and Biological Sciences14.9%
    1. Engineering19.5%
    2. Environmental Science02.0%
    3. Physics and Astronomy02.0%
    4. Chemical Engineering01.2%
    5. Chemistry00.9%
    1. Economics, Econometrics and Finance00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Coris BioConcept (Belgium)?

Ranked on the quality score, Pascal Mertens and Thierry Laurent lead among researchers whose main affiliation is Coris BioConcept (Belgium).

  1. 1 Pascal Mertens Belgium · #1,416,914 worldwide 2.9k citations · 79 works
  2. 2 Thierry Laurent Belgium · #3,475,028 worldwide 3k citations · 134 works
All ranked researchers at Coris BioConcept (Belgium)

What are the most cited papers from Coris BioConcept (Belgium)?

The most cited paper from Coris BioConcept (Belgium) is "Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic Context" (Pascal Mertens et al., 2020), with 217 citations. Next come "Molecular Dipstick Test for Diagnosis of Sleeping Sickness" (101) and "Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study" (94).

Most cited papers
#PaperReleasedCitations
1 Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic Context Pascal Mertens et al. · Frontiers in Medicine Open access 8 May 2020 217
2 Molecular Dipstick Test for Diagnosis of Sleeping Sickness Stijn Deborggraeve, Filip F. Claes, Thierry Laurent et al. · Journal of Clinical Microbiology Aug 2006 101
3 Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study Philippe Büscher, Pascal Mertens, Thierry Leclipteux et al. · The Lancet Global Health Open access 8 May 2014 94
4 A Simplified and Standardized Polymerase Chain Reaction Format for the Diagnosis of Leishmaniasis Stijn Deborggraeve, Thierry Laurent, Diego A. Espinosa et al. · The Journal of Infectious Diseases Open access 24 Sep 2008 90
5 Evaluation of two new commercial immunochromatographic assays for the rapid detection of OXA-48 and KPC carbapenemases from cultured bacteria Youri Glupczynski, Stéphanie Evrard, Isabelle Ote et al. · Journal of Antimicrobial Chemotherapy 28 Jan 2016 84
All 69 most cited papers, with filters and sorting

Which research topics does Coris BioConcept (Belgium) publish most on?

By volume in 2022-now: Antibiotic Use and Resistance, Biosensors and Analytical Detection, SARS-CoV-2 detection and testing and Bacillus and Francisella bacterial research.

Antibiotic Use and Resis…0Antibiotic Use and Resistance: 0 fractional worksBiosensors and Analytica…0Biosensors and Analytical Detection: 0 fractional worksSARS-CoV-2 detection and testing: 0 fractional worksBacillus and Francisella…0Bacillus and Francisella bacterial research: 0 fractional worksAdvanced Biosensing Tech…0Advanced Biosensing Techniques and Applications: 0 fractional worksAntibiotic Resistance in…0Antibiotic Resistance in Bacteria: 0 fractional worksHerpesvirus Infections a…0Herpesvirus Infections and Treatments: 0 fractional worksPoxvirus research and ou…0Poxvirus research and outbreaks: 0 fractional worksAntibiotics Pharmacokine…0Antibiotics Pharmacokinetics and Efficacy: 0 fractional works
Applied Microbiology and BiotechnologyBiomedical EngineeringInfectious DiseasesMolecular Biology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 0 works
  2. 2 Biosensors and Analytical Detection Biomedical Engineering 0 works
  3. 3 SARS-CoV-2 detection and testing Infectious Diseases 0 works
  4. 4 Bacillus and Francisella bacterial research Molecular Biology 0 works
  5. 5 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
  6. 6 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
  7. 7 Herpesvirus Infections and Treatments Epidemiology 0 works
  8. 8 Poxvirus research and outbreaks Virology 0 works
  9. 9 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.8%not open45.2%

World: 40% of research is openly available.

with international co-authors81.5%domestic only18.5%

World: 18% is written across borders.

How has Coris BioConcept (Belgium)'s research output changed?

Output in 2022-2025 was 79% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Coris BioConcept (Belgium) as a percentage of every work published that year, 0.0000078% in 2023.

still counting0.000020%0.000040%0.000060%Coris BioConcept (Belgium)0.0000056% in 2025200020102020

Fractional works of Coris BioConcept (Belgium) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Gembloux

All research institutions in Gembloux

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Coris BioConcept (Belgium). Posts are plain text and can be reported.